Ascendis Pharma (Brazil) Investor Sentiment

A1SN34 Stock  BRL 56.10  0.00  0.00%   
About 56% of Ascendis Pharma's investor base is looking to short. The analysis of current outlook of investing in Ascendis Pharma AS suggests that many traders are alarmed regarding Ascendis Pharma's prospects. The current market sentiment, together with Ascendis Pharma's historical and current headlines, can help investors time the market. In addition, many technical investors use Ascendis Pharma AS stock news signals to limit their universe of possible portfolio assets.
  
a day ago at news.google.com         
Ascendis Pharma ADR Joins Elite Club Of Stocks With RS Ratings Over 90 - Investors Business Daily
Google News at Macroaxis
2 days ago at news.google.com         
Ascendis Pharmas Market Strength and Positive Trial Outcomes Drive Buy Rating - TipRanks
Google News at Macroaxis
few days ago at news.google.com         
Optimistic Investors Push Ascendis Pharma AS Shares Up 26 percent But Growth Is Lacking - Simply Wal...
Google News at Macroaxis
over a week ago at news.google.com         
Sanctuary Advisors LLC Acquires Shares of 1,597 Ascendis Pharma AS - Defense World
Google News at Macroaxis
over two weeks ago at news.google.com         
If You Invested 1000 In This Stock 15 Years Ago, You Would Have This Much Today - Benzinga
Google News at Macroaxis
over three weeks ago at news.google.com         
Why Ascendis Pharma Shares Are Under Pressure - TipRanks
Google News at Macroaxis
over three weeks ago at news.google.com         
Why Ascendis Pharma Shares Are Climbing - TipRanks
Google News at Macroaxis
over three weeks ago at news.google.com         
Why Have Ascendis Pharma Stocks Skyrocketed - TipRanks
Google News at Macroaxis
over a month ago at news.google.com         
Ascendis Pharma AS Yearly Results Heres What Analysts Are Forecasting For This Year - Simply Wall St
Google News at Macroaxis
over a month ago at news.google.com         
Ascendis Pharma launches 25 million share buyback - MSN
Google News at Macroaxis
over a month ago at news.google.com         
Why Is Rare Disease Focused Ascendis Pharma Stock Trading Higher On Thursday - Benzinga
Google News at Macroaxis
over a month ago at news.google.com         
Ascendis Pharma launches 25 million share buyback - Investing.com
Google News at Macroaxis
over a month ago at news.google.com         
abrdn plc Buys 28,967 Shares of Ascendis Pharma AS - MarketBeat
Google News at Macroaxis
over a month ago at news.google.com         
Ascendis Pharma FY2024 Financial Results Key Date and Conference Details Revealed - StockTitan
Google News at Macroaxis
over a month ago at news.google.com         
Ascendis Pharmas Yorvipath Launch and Market Positioning Bolster Buy Rating - TipRanks
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Ascendis Pharma that are available to investors today. That information is available publicly through Ascendis media outlets and privately through word of mouth or via Ascendis internal channels. However, regardless of the origin, that massive amount of Ascendis data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Ascendis Pharma news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Ascendis Pharma relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Ascendis Pharma's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Ascendis Pharma alpha.

Ascendis Pharma Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Ascendis Stock analysis

When running Ascendis Pharma's price analysis, check to measure Ascendis Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ascendis Pharma is operating at the current time. Most of Ascendis Pharma's value examination focuses on studying past and present price action to predict the probability of Ascendis Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ascendis Pharma's price. Additionally, you may evaluate how the addition of Ascendis Pharma to your portfolios can decrease your overall portfolio volatility.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Fundamental Analysis
View fundamental data based on most recent published financial statements
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk